Drugmaker Novo Nordisk lowers 2017 sales, profit outlook
COPENHAGEN, Feb 2 (Reuters) - Denmark's Novo Nordisk , the world's top maker of diabetes drugs, said fourth-quarter operating profit came in a touch below forecasts and lowered its 2017 operating profit and sales growth outlook measured in local currency terms. [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: profit, operating, sales, Nordisk, terms, currency, local, outlook measured, growth, lowered, forecasts and, below, touch, said fourth-quarter, drugs, diabetes, maker, world's, Denmark's, (Reuters), COPENHAGEN, outlook, lowers, Drugmaker
